Table 1.
Characterisation of AMR genes and phylogroup in ESBL-producing E. coli strains.
| Resistant Phenotype | Phylogroup | |
|---|---|---|
| Environment | Clinical | |
| AMP_AMC_CXM_NAL_CHL | B2 | |
| CRO_AMP_AMC_CXM_CIP | B2 | A, B2, F |
| CRO_AMP_AMC_CXM_CIP_CHL | B2 | |
| CRO_AMP_AMC_CXM_CIP_CHL_CN | A | |
| CRO_AMP_AMC_CXM_CIP_CHL_MEM_IMP | A | |
| CRO_AMP_AMC_CXM_CIP_CN | B2 | A, B2 |
| CRO_AMP_AMC_CXM_CIP_NAL | A, B1 | |
| CRO_AMP_AMC_CXM_CIP_NAL_SXT | C | |
| CRO_AMP_AMC_CXM_CIP_NAL_SXT_CN | A | |
| CRO_AMP_AMC_CXM_CIP_SXT | A, B2, C, D, G | |
| CRO_AMP_AMC_CXM_CIP_SXT_CHL | B2 | |
| CRO_AMP_AMC_CXM_CIP_SXT_CN | B2 | |
| CRO_AMP_AMC_CXM_CIP_SXT_CN_IMP_MEM | C | |
| CRO_AMP_AMC_CXM_CIP_SXT_NAL | B2 | A, B2 |
| CRO_AMP_AMC_CXM_SXT_CHL | B1 | |
| CRO_AMP_AMC_SXT_CHL | B1 | |
| CRO_AMP_AMC_SXT_CHL_CN | B1 | |
| CRO_AMP_AMC_SXT_CIP_NAL | A, C | |
| CRO_AMP_CXM_CIP_NAL | B2 | |
| CRO_AMP_CXM_CIP_SXT | B2 | |
| CRO_AMP_CXM_CIP_SXT_AMC_NAL | B1, B2 | |
| CRO_AMP_CXM_CIP_SXT_NAL | B2 | |
| CRO_AMP_CXM_CIP_SXT_NAL_CHL_CN | B2 | |
| CRO_AMP_SXT_CXM_CHL | B2 | |
| CRO_AMP_SXT_CXM_CIP | B2 | |
Key: AMP (ampicillin); AMC (amoxicillin-clavulanic acid); CXM (cefuroxime); NAL (nalidixic acid); CHL (chloramphenicol); CRO (ceftriaxone); CIP (ciprofloxacin); SXT (trimethoprim-sulfamethoxazole); CN (gentamicin); MEM (meropenem); IMP (imipenem).